1. Home
  2. SOWG vs CCEL Comparison

SOWG vs CCEL Comparison

Compare SOWG & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sow Good Inc.

SOWG

Sow Good Inc.

HOLD

Current Price

$1.44

Market Cap

35.7M

ML Signal

HOLD

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

HOLD

Current Price

$3.63

Market Cap

29.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOWG
CCEL
Founded
2010
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Managed Health Care
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.7M
29.6M
IPO Year
2011
2022

Fundamental Metrics

Financial Performance
Metric
SOWG
CCEL
Price
$1.44
$3.63
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
1.1M
9.5K
Earning Date
05-15-2026
04-14-2026
Dividend Yield
N/A
4.26%
EPS Growth
N/A
N/A
EPS
N/A
0.01
Revenue
N/A
$25,384,279.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$354.00
Revenue Growth
N/A
9.76
52 Week Low
$0.10
$2.72
52 Week High
$2.12
$5.52

Technical Indicators

Market Signals
Indicator
SOWG
CCEL
Relative Strength Index (RSI) 66.21 49.49
Support Level $0.40 $3.18
Resistance Level $1.80 $3.57
Average True Range (ATR) 0.11 0.30
MACD 0.11 -0.03
Stochastic Oscillator 79.45 17.39

Price Performance

Historical Comparison
SOWG
CCEL

About SOWG Sow Good Inc.

Sow Good Inc is engaged in manufacturing and marketing freeze-dried fruits, vegetables, snacks, smoothies, and soups. The company also sells gluten-free products under the Sow Good brand. The company is developing a freeze-dried candy market and snack manufacturing to provide consumers with flavorful freeze-dried treats. The company operates in one reportable segment, reflecting its capital-light business model under which it earns proceeds from the sale of freeze-dried candy products.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Share on Social Networks: